APA (7th ed.) Citation

Foley, P., Kerdraon, Y. A., Hogden, J. P., Shumack, S., Spelman, L., Sebaratnam, D. F., . . . Katelaris, C. H. (2022). Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting. Australasian Journal of Dermatology, 63(4), 421. https://doi.org/10.1111/ajd.13924

Chicago Style (17th ed.) Citation

Foley, Peter, Yves A. Kerdraon, John P. Hogden, Stephen Shumack, Lynda Spelman, Deshan F. Sebaratnam, Charles S. Su, and Constance H. Katelaris. "Dupilumab‐associated Ocular Surface Disease: An Interdisciplinary Decision Framework for Prescribers in the Australian Setting." Australasian Journal of Dermatology 63, no. 4 (2022): 421. https://doi.org/10.1111/ajd.13924.

MLA (9th ed.) Citation

Foley, Peter, et al. "Dupilumab‐associated Ocular Surface Disease: An Interdisciplinary Decision Framework for Prescribers in the Australian Setting." Australasian Journal of Dermatology, vol. 63, no. 4, 2022, p. 421, https://doi.org/10.1111/ajd.13924.